Disordered Purinergic Signaling Inhibits Pathological Angiogenesis in Cd39/Entpd1-Null Mice
- 31 October 2007
- journal article
- Published by Elsevier BV in The American Journal of Pathology
- Vol. 171 (4), 1395-1404
- https://doi.org/10.2353/ajpath.2007.070190
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppressionThe Journal of Experimental Medicine, 2007
- A2A adenosine receptor protects tumors from antitumor T cellsProceedings of the National Academy of Sciences, 2006
- RanBPM associates with CD39 and modulates ecto-nucleotidase activityBiochemical Journal, 2006
- RanBPM Is a Phosphoprotein That Associates with the Plasma Membrane and Interacts with the Integrin LFA-1Journal of Biological Chemistry, 2004
- Integrins in angiogenesis: multitalented molecules in a balancing actCell and tissue research, 2003
- Regulation of G Protein–Coupled Receptor Signaling by Scaffold ProteinsCirculation Research, 2002
- Activation of Ras/Erk Pathway by a Novel MET-interacting Protein RanBPMPublished by Elsevier BV ,2002
- Seven-transmembrane receptorsNature Reviews Molecular Cell Biology, 2002
- Enhanced pathological angiogenesis in mice lacking β3 integrin or β3 and β5 integrinsNature Medicine, 2002
- Patterns and Emerging Mechanisms of the Angiogenic Switch during TumorigenesisCell, 1996